DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Manufacturing Market Research Report by Drug Development Type, Formulation, Therapy Area, Route of Administration Outlook, Prescription , Age Group, Distribution Channels, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Pharmaceutical Manufacturing Market size was estimated at USD 405.52 billion in 2020, is expected to reach USD 454.02 billion in 2021, and projected to grow at a CAGR of 12.29% reaching USD 813.31 billion by 2026.
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Drug Development Type, the market was studied across In-house and Outsource.
- Based on Formulation, the market was studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets.
- Based on Therapy Area, the market was studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases.
- Based on Route of Administration Outlook, the market was studied across Inhalations, Oral, Parenteral, and Topical.
- Based on Prescription, the market was studied across Over-the-counter (OTC) Medicines and Prescription Medicines.
- Based on Age Group, the market was studied across Adults, Children & Adolescents, and Geriatric.
- Based on Distribution Channels, the market was studied across Non-retail and Retail.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Market Dynamics
Drivers
- Increase in global demand for vaccines and drugs
- Growing pharmaceutical R&D spending
- Growth in geriatric population and incidence rate of chronic disorders
Restraints
- Patent expiration of profitable drugs
Opportunities
- Rise in focus towards healthcare needs of emerging nations
- Rise in the investment and funding programs in pharmaceutical manufacturing sector
- Emergence in the advancements of pharmaceutical manufacturing technologies
Challenges
- Logistics complexities and limited skilled professionals
The report provides insights on the following:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Manufacturing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Manufacturing Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Dynamics
6. Pharmaceutical Manufacturing Market, by Drug Development Type
7. Pharmaceutical Manufacturing Market, by Formulation
8. Pharmaceutical Manufacturing Market, by Therapy Area
9. Pharmaceutical Manufacturing Market, by Route of Administration Outlook
10. Pharmaceutical Manufacturing Market, by Prescription
11. Pharmaceutical Manufacturing Market, by Age Group
12. Pharmaceutical Manufacturing Market, by Distribution Channels
13. Americas Pharmaceutical Manufacturing Market
14. Asia-Pacific Pharmaceutical Manufacturing Market
15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market
16. Competitive Landscape
17. Company Usability Profiles
- Actiza Pharmaceutical Pvt. Ltd.
- Aenova Group GmbH
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim Group
- Bristol-Myers Squibb
- Catalent Inc.
- Eli Lilly And Company
- F. Hoffmann-La Roche Ltd.
- Famar SA
- GlaxoSmithKline PLC
- Johnson & Johnson Private Limited
- Lonza Group AG
- Merck & Co. Inc.
- Novartis AG
- Pfizer, Inc.
- Piramal Pharma Solutions
- Recipharm AB
- Sanofi S.A.
- Sun Pharmaceutical Industries Limited
For more information about this report visit https://www.researchandmarkets.com/r/i5nmnp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
